Advisory Commission on Childhood Vaccines, 63485-63486 [2016-22193]

Download as PDF sradovich on DSK3GMQ082PROD with NOTICES Federal Register / Vol. 81, No. 179 / Thursday, September 15, 2016 / Notices physiologic newborn screening examination prior to discharge from the newborn nursery. As stated in the funding opportunity announcement (FOA) HRSA 15–085, the focus of the NTRC is to provide to state Early Hearing Detection and Intervention (EHDI) programs training and technical assistance for planning, policy development, implementing innovations, and quality improvement methodology to reduce their loss to follow-up rate/loss to documentation, i.e. the number of infants who do not receive timely and appropriate screening follow-up and coordinated interventions. Since the publication of the FOA on September 9, 2014, many changes in research, policy, technology, and practice have occurred in the newborn hearing screening field in the areas of family engagement, early language acquisition, and early literacy. The NTRC cooperative agreement must address these changes to provide appropriate training and technical assistance. The Maternal and Child Health Bureau (MCHB) proposes to supplement the recipient in FY 2016 and 2017 to address new research, approaches, and practice advances in the field of family engagement. MCHB proposes to supplement the recipient in FY 2018 and 2019 to address the latest research findings and advances related to early language acquisition and early literacy. Funding in FY 2017, FY 2018, and FY 2019 is contingent upon appropriations, satisfactory performance of the recipient, need, and availability of funds. According to the National Institute for Children’s Health Quality, families have a unique perspective on how the system currently affects them personally and can provide invaluable viewpoints on the steps that can be implemented to improve the system. Since the system exists to meet the needs of the deaf or hard of hearing infants and children, it is critical that their parents and families’ viewpoints are acknowledged and leveraged. MCHB recommends greater representation of individuals who are deaf or hard of hearing throughout the NTRC as well as providing opportunities for families of deaf or hard of hearing children to become leaders within the EHDI system. To address these deficiencies, Utah State University submitted a prior approval request for funds to improve its family engagement. The NTRC will take a streamlined and targeted approach toward engaging families and family based organizations in its work. Though not introducing new services or activities, the NTRC will use the VerDate Sep<11>2014 17:34 Sep 14, 2016 Jkt 238001 supplemental funds to refine its current services and activities to: 1. Increase and refocus the family advisory committee to be more reflective of families who have a deaf or hard of hearing child; 2. Target the NTRC’s scholarship program toward greater family engagement and leadership development; 3. Enhance family engagement in EHDI quality improvement activities; and 4. Increase the NTRC’s financial and programmatic support for the work by Hands & Voices to strengthen family engagement in EHDI programs. This will be the second supplement for this cooperative agreement. FOR FURTHER INFORMATION CONTACT: Sadie Silcott, MBA, MPH, Division of Services for Children with Special Health Needs, Maternal and Child Health Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 18W57, Rockville, Maryland 20857; Phone: (301) 443– 0133; Email: ssilcott@hrsa.gov. Dated: September 2, 2016. James Macrae, Acting Administrator. [FR Doc. 2016–21711 Filed 9–14–16; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration Advisory Commission on Childhood Vaccines Health Resources and Service Administration, HHS. ACTION: Notice of Meeting. AGENCY: In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given that a meeting is scheduled for Advisory Commission on Childhood Vaccines (ACCV). This meeting will be open to the public. Information about the ACCV and the agenda for this meeting can be obtained by accessing the following Web site: http://www.hrsa.gov/ advisorycommittees/childhoodvaccines/ index.html. DATES: The meeting will be held on September 20, 2016, at 10:00 a.m. EDT. ADDRESSES: This meeting will be held via Adobe Connect Webinar and teleconference. The address for the meeting is 5600 Fishers Lane, Rockville, MD 20857, Conference Room 09N17. The public can join the meeting by: SUMMARY: PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 63485 1. (Audio Portion) Calling the conference phone number 800–799– 3561 and providing the following information: Leader Name: Dr. Narayan Nair Password: 8164763 2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro Meeting using the following URL: https:// hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work directly, and enter as a guest). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL:https:// hrsa.connectsolutions.com/common/ help/en/support/meeting_test.htm and get a quick overview by following URL: http://www.adobe.com/go/connectpro_ overview. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACCV should contact Annie Herzog, Program Analyst, Division of Injury Compensation Programs (DICP), Health Resources and Services Administration, in one of three ways: (1) Send a request to the following address: Annie Herzog, Program Analyst, DICP, Health Resources and Services Administration, 5600 Fishers Lane, Room 08N146B, Rockville, Maryland 20857; (2) call (301) 443– 6593; or (3) send an email to aherzog@ hrsa.gov. SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of the Public Health Service Act (the Act) (42 U.S.C. 300aa–19), as enacted by Public Law (Pub. L.) 99–660, and as subsequently amended, and advises the Secretary of Health and Human Services (the Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). The activities of the ACCV also include: Recommending changes in the Vaccine Injury Table at its own initiative or as the result of the filing of a petition; advising the Secretary in implementing section 2127 of the Act regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions; surveying federal, state, and local programs and activities related to gathering information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b) of the Act; advising the Secretary on the methods of obtaining, compiling, publishing, and using credible data related to the frequency and severity of adverse E:\FR\FM\15SEN1.SGM 15SEN1 63486 Federal Register / Vol. 81, No. 179 / Thursday, September 15, 2016 / Notices reactions associated with childhood vaccines; consulting on the development or revision of Vaccine Information Statements; and recommending to the Director of the National Vaccine Program research related to vaccine injuries which should be conducted to carry out the VICP. During the September 20 meeting, the agenda items will include, but are not limited to, updates from the Division of Injury Compensation Programs (DICP), Department of Justice (DOJ), National Vaccine Program Office (NVPO), Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health) and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http:// www.hrsa.gov/advisorycommittees/ childhoodvaccines/index.html) prior to the meeting. Agenda items are subject to change as priorities dictate. Members of the public will have the opportunity to provide comments. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to make oral comments or provide written comments to the ACCV should be sent to Annie Herzog using the address or phone number above by September 18, 2016. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Annie Herzog, using the address and phone number by September 16. Jason E. Bennett, Director, Division of the Executive Secretariat. [FR Doc. 2016–22193 Filed 9–14–16; 8:45 am] BILLING CODE 4165–15–P both new opportunities and emerging needs for incorporation in the programmatic efforts of the Office. A draft is available on the ODS Web site at ods.od.nih.gov/StrategicPlan. DATES: In order to ensure full consideration, all responses must be submitted by 11:59 p.m., September 30, 2016. ADDRESSES: Interested individuals and organizations should submit their responses to ODSplan@od.nih.gov. FOR FURTHER INFORMATION CONTACT: Anne L. Thurn, Ph.D., Office of Dietary Supplements, National Institutes of Health, 6100 Executive Boulevard, Room 3B01, Bethesda, MD 20892–7517, Phone: 301–435–2920, Fax: 301–480– 1845, Email: ODSplan@od.nih.gov. SUPPLEMENTARY INFORMATION: ODS has drafted its next Strategic Plan and desires public comment on the progress of its programs and on future needs and opportunities for program activities. The draft plan and related information are available on the ODS Web site at ods.od.nih.gov/StrategicPlan. Guidance is being requested from all interested parties on these important issues: • Are the current strategic goals adequate? • Is ODS meeting its stakeholders’ needs? • In the future, should some of ODS’s current programs or activities be given higher (or lower) priority? • How can ODS more effectively provide useful information to the ODS user community, including consumers, investigators, practitioners, industry, media, policy makers, government, and other interested parties? Dated: September 9, 2016. Lawrence Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2016–22233 Filed 9–14–16; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Opportunity for Public Comment on the Office of Dietary Supplements Draft 2016–2021 Strategic Plan sradovich on DSK3GMQ082PROD with NOTICES 17:34 Sep 14, 2016 Jkt 238001 Dated: September 9, 2016. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–22165 Filed 9–14–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) has initiated a strategic planning process that will culminate in the ODS Strategic Plan for 2016–2021. To assist with this process, the ODS requests input from research communities—academic, government, and industry—and from other interested parties. The overall purpose of the strategic planning effort is to identify VerDate Sep<11>2014 Name of Committee: National Institute of Mental Health Special Emphasis Panel; Pilot Effectiveness Studies and Services Research Grants. Date: October 7, 2016. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Monaco, 700 F Street NW., Washington, DC 20001. Contact Person: Aileen Schulte, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH Neuroscience Center, 6001 Executive Blvd., Room 6140, MSC 9608, Bethesda, MD 20892–9608, 301–443–1225, aschulte@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Research Education Programs (R25). Date: October 13, 2016. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: David M. Armstrong, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH Neuroscience Center/ Room 6138/MSC 9608, 6001 Executive Boulevard, Bethesda, MD 20892–9608, 301– 443–3534, armstrda@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) BILLING CODE 4140–01–P National Institutes of Health SUMMARY: confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial E:\FR\FM\15SEN1.SGM 15SEN1

Agencies

[Federal Register Volume 81, Number 179 (Thursday, September 15, 2016)]
[Notices]
[Pages 63485-63486]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22193]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Service Administration


Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Service Administration, HHS.

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given that a meeting 
is scheduled for Advisory Commission on Childhood Vaccines (ACCV). This 
meeting will be open to the public. Information about the ACCV and the 
agenda for this meeting can be obtained by accessing the following Web 
site: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.

DATES: The meeting will be held on September 20, 2016, at 10:00 a.m. 
EDT.

ADDRESSES: This meeting will be held via Adobe Connect Webinar and 
teleconference. The address for the meeting is 5600 Fishers Lane, 
Rockville, MD 20857, Conference Room 09N17. The public can join the 
meeting by:
    1. (Audio Portion) Calling the conference phone number 800-799-3561 
and providing the following information:

Leader Name: Dr. Narayan Nair
Password: 8164763

    2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro 
Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work 
directly, and enter as a guest). Participants should call and connect 
15 minutes prior to the meeting in order for logistics to be set up. If 
you have never attended an Adobe Connect meeting, please test your 
connection using the following URL:https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by 
following URL: http://www.adobe.com/go/connectpro_overview.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the ACCV should contact Annie Herzog, Program Analyst, 
Division of Injury Compensation Programs (DICP), Health Resources and 
Services Administration, in one of three ways: (1) Send a request to 
the following address: Annie Herzog, Program Analyst, DICP, Health 
Resources and Services Administration, 5600 Fishers Lane, Room 08N146B, 
Rockville, Maryland 20857; (2) call (301) 443-6593; or (3) send an 
email to aherzog@hrsa.gov.

SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of 
the Public Health Service Act (the Act) (42 U.S.C. 300aa-19), as 
enacted by Public Law (Pub. L.) 99-660, and as subsequently amended, 
and advises the Secretary of Health and Human Services (the Secretary) 
on issues related to implementation of the National Vaccine Injury 
Compensation Program (VICP).
    The activities of the ACCV also include: Recommending changes in 
the Vaccine Injury Table at its own initiative or as the result of the 
filing of a petition; advising the Secretary in implementing section 
2127 of the Act regarding the need for childhood vaccination products 
that result in fewer or no significant adverse reactions; surveying 
federal, state, and local programs and activities related to gathering 
information on injuries associated with the administration of childhood 
vaccines, including the adverse reaction reporting requirements of 
section 2125(b) of the Act; advising the Secretary on the methods of 
obtaining, compiling, publishing, and using credible data related to 
the frequency and severity of adverse

[[Page 63486]]

reactions associated with childhood vaccines; consulting on the 
development or revision of Vaccine Information Statements; and 
recommending to the Director of the National Vaccine Program research 
related to vaccine injuries which should be conducted to carry out the 
VICP.
    During the September 20 meeting, the agenda items will include, but 
are not limited to, updates from the Division of Injury Compensation 
Programs (DICP), Department of Justice (DOJ), National Vaccine Program 
Office (NVPO), Immunization Safety Office (Centers for Disease Control 
and Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health) and Center for Biologics, Evaluation 
and Research (Food and Drug Administration). A draft agenda and 
additional meeting materials will be posted on the ACCV Web site 
(http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html) 
prior to the meeting. Agenda items are subject to change as priorities 
dictate.
    Members of the public will have the opportunity to provide 
comments. Oral comments will be honored in the order they are requested 
and may be limited as time allows. Requests to make oral comments or 
provide written comments to the ACCV should be sent to Annie Herzog 
using the address or phone number above by September 18, 2016. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify Annie Herzog, using the address and phone number by September 
16.

Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016-22193 Filed 9-14-16; 8:45 am]
 BILLING CODE 4165-15-P